---
figid: PMC11201201__biomedicines-12-01328-g002
figtitle: VEGFR activation by the VEGF family of growth factors and resulting downstream
  signaling pathways to angiogenesis and lymphangiogenesis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11201201
filename: biomedicines-12-01328-g002.jpg
figlink: /pmc/articles/PMC11201201/figure/F2
number: F2
caption: 'VEGFR activation by the VEGF family of growth factors and resulting downstream
  signaling pathways to angiogenesis and lymphangiogenesis. Family of glycoproteins
  including placental growth factors (PIGF) and VEGF-A, -B, -C, and -D bind to extracellular
  immunoglobulin (Ig) loops of VEGFR-1, -2, and-3. VEGFR-1 and -2 are mostly expressed
  on endothelial cells (ECs) and some cancer cells. This binding activates downstream
  signaling pathways, including RAS-RAF-MEK-ERK, as well as PI3K-AKT-mTOR and NCK-MAPK
  2/3. Reproduced with permission from Wang, L., Liu, W-Q., Broussy, S. Han, B. and
  Fang H. Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis.
  Front Pharmacol, 2024, 14, 1307860, doi: 10.3389/fphar.2023.1307860 [46]'
papertitle: Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the
  Pathogenesis of iMCD-TAFRO
reftext: Gordan Srkalovic, et al. Biomedicines. 2024 Jun;12(6).
year: '2024'
doi: 10.3390/biomedicines12061328
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: VEGF | TAFRO | i-MCD | IL-6 | mTOR | signaling pathways
automl_pathway: 0.9514226
figid_alias: PMC11201201__F2
figtype: Figure
redirect_from: /figures/PMC11201201__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11201201__biomedicines-12-01328-g002.html
  '@type': Dataset
  description: 'VEGFR activation by the VEGF family of growth factors and resulting
    downstream signaling pathways to angiogenesis and lymphangiogenesis. Family of
    glycoproteins including placental growth factors (PIGF) and VEGF-A, -B, -C, and
    -D bind to extracellular immunoglobulin (Ig) loops of VEGFR-1, -2, and-3. VEGFR-1
    and -2 are mostly expressed on endothelial cells (ECs) and some cancer cells.
    This binding activates downstream signaling pathways, including RAS-RAF-MEK-ERK,
    as well as PI3K-AKT-mTOR and NCK-MAPK 2/3. Reproduced with permission from Wang,
    L., Liu, W-Q., Broussy, S. Han, B. and Fang H. Recent advances of anti-angiogenic
    inhibitors targeting VEGF/VEGFR axis. Front Pharmacol, 2024, 14, 1307860, doi:
    10.3389/fphar.2023.1307860 [46]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIGF
  - PGF
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FLT1
  - KDR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NCK1
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TUBE1
  - FLT4
  - RAS
  - MEK
---
